Intellia Therapeutics to Present at October Healthcare Investor Conferences
24 Septembre 2018 - 2:30PM
Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing
company focused on the development of curative therapeutics using
CRISPR/Cas9 technology, will participate in the following upcoming
healthcare conferences in October:
Monday, October 1, 2018Cantor
Fitzgerald Healthcare ConferenceLocation: New York,
NYTime: 4:40pm ET
Tuesday, October 2, 2018Leerink
Partners Roundtable Series: Rare Disease &
OncologyLocation: New York, NYTime: 10:30am ET
Tuesday, October 9, 2018Chardan Genetic
Medicines ConferenceLocation: New York, NYTime: 1:30pm
ET
A live webcast of Intellia’s presentations will be accessible
through the Events and Presentations page of the Investor Relations
section of the company’s website at www.intelliatx.com. To access
the webcasts, please log on to the Intellia website approximately
15 minutes prior to the start time to ensure adequate time for any
software downloads that may be required. A replay of the webcasts
will be available on Intellia’s website for approximately 14 days
following each conference.
About Intellia Therapeutics
Intellia Therapeutics is a leading genome editing company
focused on developing proprietary, curative therapeutics using the
CRISPR/Cas9 system. Intellia believes the CRISPR/Cas9 technology
has the potential to transform medicine by permanently editing
disease-associated genes in the human body with a single treatment
course, and through improved cell therapies that can treat cancer
and immunological diseases by replacing patients’ diseased cells.
The combination of deep scientific, technical and clinical
development experience, along with its leading intellectual
property portfolio, puts Intellia in a unique position to unlock
broad therapeutic applications of the CRISPR/Cas9 technology and
create a new class of therapeutic products. Learn more about
Intellia Therapeutics and CRISPR/Cas9 at intelliatx.com and follow
us on Twitter @intelliatweets.
Investor
Contact:
Lindsey Trickett Vice President, Investor Relations +1
857-285-6211lindsey.trickett@intelliatx.com
Media Contact:Jennifer Mound Smoter Senior Vice
President, External Affairs & Communications +1 857-706-1071
jenn.smoter@intelliatx.com
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Intellia Therapeutics (NASDAQ:NTLA)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024